Dr. Kamala Maddali is a clinically trained veterinarian who holds a doctorate in veterinary medicine from the Sri Venkateswara Veterinary University in India and a doctorate in pharmacology from the University of Missouri-Columbia. Dr. Maddali is a native of Andhra Pradesh, India. Dr. Maddali is a precision medicine executive at Fortune 100 and 500 companies like Merck & Co, Quintiles, IQVIA, Quest Diagnostics, Dr. Maddali has extensive knowledge in the field. With over 20 years of experience implementing corporate strategic initiatives, she has helped advance precision medicine over the last two decades. Dr. Maddali is now the Global Vice President of Deep Lens Inc., an artificial intelligence company specializing in recruiting patients for clinical trials in precision medicine.

Dr. Maddali has strong medical, scientific as well as rare disease roots, which gives her an edge as a visionary leader who fosters collaboration between medical, patient, and healthcare innovation sectors. Among her expertise is Precision Medicine including diagnostics such as biomarkers and companion diagnostics, devices, therapeutics, recruitment of patients, patient engagement, patient experience and empowerment. Several healthcare technology companies have tapped Dr. Maddali to serve as an executive advisor to cultivate artificial intelligence, digital health, and solutions centered on modern precision medicine. With the increased interest in patient centricity in clinical trials and clinical research, her unique involvement with Patient Advocacy and support groups in converging precision medicine, clinical trials and clinical research could make a significant difference. Whenever possible, Dr. Maddali wants to ensure the patient's voice is heard, and she strives to provide every patient with powerful tools from science and innovation in order to improve global community health. Her personal experience as a rare disease neuro – degenerative patient with signs similar to Multiple Sclerosis and Parkinson's makes her a unique, empathic voice in precision medicine.

Dr. Maddali is a board member for several US/International based patient advocacy associations like "Paltown", "Cancer NJ", Love Heals Cancer, Aarogya, Indo-US Rare disease organization, Adira Foundation working to foster knowledge about cancer, rare disease diagnosis and prevention, and neuro-degenerative disease management. She has earned the trust of patients, oncologists, and KOLs by her involvement in patient advocacy. NJBIZ has selected Dr. Maddali as one of the Healthcare Heroes Finalists in the "Innovation-Individual" category. Doctor Maddali has received many awards for women empowerment in healthcare from various organizations in the USA. Dr. Maddali served as a Vice Chair for the Women in Bio (WIB) Philadelphia chapter. The Women In Bio organization promotes careers, leadership, and entrepreneurship for women in the life sciences. Dr. Maddali and a few prominent WIB leaders were invited to ring the NYSE Closing Bell in 2017 and was interviewed by CNBC in December 2018 on Precision Medicine and Blockchain. As a member of Forbes Business Council in 2020, Dr. Maddali is commended for her distinguished leadership in the healthcare industry.

In 2021, Dr. Kamala Maddali was awarded Pharma Voice 2021 Top 100 Most Inspiring Leaders in the Life Sciences and Healthcare Industry. The award is prestigious and honorable recognition to be a part of a select group of leaders, mentors, and visionaries in the Life Sciences who inspire change across their organizations, including Fortune 100 and 500 companies. Dr. Maddali is the author of "Becoming a Kamala" a memoir focused on her unique journey which unveils her various avatars in her pursuit towards becoming a better human, woman and a rare disease patient.